Globus Medical saw $274.5 million in the fourth quarter, a 9.8 percent increase year-over-year, according to financial results posted Feb. 21. In 2022, the company surpassed $1 billion in revenue. President and CEO Dan Scavilla said Globus Medical saw record U.S. spine sales in the fourth quarter.
NuVasive saw $1.2 billion in net sales during 2022, a 5.5 percent increase compared to 2021, according to financial results posted Feb. 22. In the fourth quarter, NuVasive saw $305.4 million, a 1.1 percent increase year-over-year. However, net sales were negatively impacted by about $34 million in 2022 due to fluctuations in foreign currency exchange rates.
Both companies will combine later in 2023. Globus Medical plans to acquire NuVasive in a deal valuing the devicemaker at $3.1 billion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
